1,013
Views
3
CrossRef citations to date
0
Altmetric
Report

Time-lapse microscopic observation of non-dividing cells in cultured human osteosarcoma MG-63 cell line

ORCID Icon, , , , ORCID Icon, , , , , & ORCID Icon show all
Pages 174-181 | Received 11 Jul 2017, Accepted 17 Oct 2017, Published online: 26 Dec 2017

References

  • Li L, Clevers H. Coexistence of quiescent and active adult stem cells in mammals. Science. 2010;327:542–545. doi:10.1126/science.1180794. PMID:20110496
  • Doupe DP, Alcolea MP, Roshan A, et al. A single progenitor population switches behavior to maintain and repair esophageal epithelium. Science. 2012;337:1091–1093. 10.1126/science.1218835. PMID:22821983
  • Hsu YC, Li L, Fuchs E. Transit-amplifying cells orchestrate stem cell activity and tissue regeneration. Cell. 2014;157:935–949. doi:10.1016/j.cell.2014.02.057. PMID:24813615
  • Insco ML, Leon A, Tam CH, et al. Accumulation of a differentiation regulator specifies transit amplifying division number in an adult stem cell lineage. Proc Natl Acad Sci USA. 2009;106:22311–22316. doi:10.1073/pnas.0912454106. PMID:20018708
  • Sanchez Alvarado A, Yamanaka S. Rethinking differentiation: stem cells, regeneration, and plasticity. Cell. 2014;157:110–119. doi:10.1016/j.cell.2014.02.041. PMID:24679530
  • Rojas-Rios P, Gonzalez-Reyes A. Concise review: The plasticity of stem cell niches: a general property behind tissue homeostasis and repair. Stem Cells. 2014;32:852–859. doi:10.1002/stem.1621. PMID:24356972
  • Grayson WL, Bunnell BA, Martin E, et al. Stromal cells and stem cells in clinical bone regeneration. Nat Rev Endocrinol. 2015;11:140–150. doi:10.1038/nrendo.2014.234. PMID:25560703
  • Blau HM, Cosgrove BD, Ho AT. The central role of muscle stem cells in regenerative failure with aging. Nat Med. 2015;21:854–862. doi:10.1038/nm.3918. PMID:26248268
  • Morrison SJ, Spradling AC. Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell. 2008;132:598–611. doi:10.1016/j.cell.2008.01.038. PMID:18295578
  • Rezza A, Sennett R, Rendl M. Adult stem cell niches: cellular and molecular components. Curr Top Dev Biol. 2014;107:333–372. doi:10.1016/B978-0-12-416022-4.00012-3. PMID:24439812
  • Cotsarelis G, Sun TT, Lavker RM. Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell. 1990;61:1329–1337. doi:10.1016/0092-8674(90)90696-C. PMID:2364430
  • Heimfeld S, Hudak S, Weissman I, et al. The in vitro response of phenotypically defined mouse stem cells and myeloerythroid progenitors to single or multiple growth factors. Proc Natl Acad Sci USA. 1991;88:9902–9906. doi:10.1073/pnas.88.21.9902. PMID:1946416
  • Digirolamo CM, Stokes D, Colter D, et al. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Brit J Haematol. 1999;107:275–281. doi:10.1046/j.1365-2141.1999.01715.x. PMID:10583212
  • Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105–111. doi:10.1038/35102167. PMID:11689955
  • Malanchi I, Santamaria-Martinez A, Susanto E, et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature. 2012;481:85–89. doi:10.1038/nature10694.
  • Moore N, Lyle S. Quiescent, slow-cycling stem cell populations in cancer: a review of the evidence and discussion of significance. J Oncol. 2011;2011. doi:10.1155/2011/396076. PMID:20936110
  • Hurt EM, Chan K, Serrat MA, et al. Identification of vitronectin as an extrinsic inducer of cancer stem cell differentiation and tumor formation. Stem Cells. 2010;28:390–398. PMID:19998373
  • Clevers H. The cancer stem cell: premises, promises and challenges. Nat Med. 2011;17:313–319. doi:10.1038/nm.2304. PMID:21386835
  • Soda Y, Marumoto T, Friedmann-Morvinski D, et al. From the cover: Feature article: Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc Natl Acad Sci USA. 2011;108:4274–4280. doi:10.1073/pnas.1016030108. PMID:21262804
  • Wang R, Chadalavada K, Wilshire J, et al. Glioblastoma stem-like cells give rise to tumour endothelium. Nature. 2010;468:829–833. doi:10.1038/nature09624. PMID:21102433
  • Ricci-Vitiani L, Pallini R, Biffoni M, et al. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature. 2010;468:824–828. doi:10.1038/nature09557. PMID:21102434
  • Kofman AV, Abounader R. When tumor cells make blood vessels: implications for glioblastoma therapy. Future Oncol. 2011;7:841–843. doi:10.2217/fon.11.58. PMID:21732755
  • Boral D, Nie D. Cancer stem cells and niche mircoenvironments. Front Biosci. 2012;4:2502–2514.
  • Gao MQ, Choi YP, Kang S, et al. CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells. Oncogene. 2010;29:2672–2680. doi:10.1038/onc.2010.35. PMID:20190812
  • Dembinski JL, Krauss S. A distinct slow-cycling cancer stem-like subpopulation of pancreatic adenocarcinoma cells is maintained in Vivo. Cancers. 2010;2:2011–2025. doi:10.3390/cancers2042011. PMID:24281215
  • Roberts PE. Isolation and establishment of human tumor stem cells. Met Cell Biol. 2008;86:325–342. doi:10.1016/S0091-679X(08)00015-0. PMID:18442655
  • Lou H, Dean M. Targeted therapy for cancer stem cells: the patched pathway and ABC transporters. Oncogene. 2007;26:1357–1360. doi:10.1038/sj.onc.1210200. PMID:17322922
  • Moore N, Houghton J, Lyle S. Slow-cycling therapy-resistant cancer cells. Stem Cells Dev. 2012;21:1822–1830. doi:10.1089/scd.2011.0477. PMID:21973238
  • Kang MK, Kang SK. Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma. Stem Cells Dev. 2007;16:837–847. doi:10.1089/scd.2007.0006. PMID:17999604
  • Essers MA, Trumpp A. Targeting leukemic stem cells by breaking their dormancy. Mol Oncol. 2010;4:443–450. doi:10.1016/j.molonc.2010.06.001. PMID:20599449
  • Li S, Kennedy M, Payne S, et al. Model of tumor dormancy/recurrence after short-term chemotherapy. PloS One. 2014;9:e98021. doi:10.1371/journal.pone.0098021. PMID:24845582
  • Touil Y, Igoudjil W, Corvaisier M, et al. Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes/YAP axis. Clin Cancer Res. 2014;20:837–846. doi:10.1158/1078-0432.CCR-13-1854. PMID:24323901
  • Harris AL. Hypoxia–a key regulatory factor in tumour growth. Nat Rev Cancer. 2002;2:38–47. doi:10.1038/nrc704. PMID:11902584
  • Strese S, Fryknas M, Larsson R, et al. Effects of hypoxia on human cancer cell line chemosensitivity. BMC Cancer. 2013;13:331. doi:10.1186/1471-2407-13-331. PMID:23829203
  • Mao Q, Zhang Y, Fu X, et al. A tumor hypoxic niche protects human colon cancer stem cells from chemotherapy. J Cancer Res Clin Oncol. 2013;139:211–222. doi:10.1007/s00432-012-1310-3. PMID:23052691
  • Pece S, Tosoni D, Confalonieri S, et al. Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell. 2010;140:62–73. doi:10.1016/j.cell.2009.12.007. PMID:20074520
  • Fujita T, Chiwaki F, Takahashi RU, et al. Identification and Characterization of CXCR4-Positive Gastric Cancer Stem Cells. PloS One. 2015;10:e0130808. doi:10.1371/journal.pone.0130808. PMID:26110809
  • Puca F, Colamaio M, Federico A, et al. HMGA1 silencing restores normal stem cell characteristics in colon cancer stem cells by increasing p53 levels. Oncotarget. 2014;5:3234–3245. doi:10.18632/oncotarget.1914. PMID:24833610
  • Hoe SL, Tan LP, Jamal J, et al. Evaluation of stem-like side population cells in a recurrent nasopharyngeal carcinoma cell line. Cancer Cell Int. 2014;14:101. doi:10.1186/s12935-014-0101-0. PMID:25317078
  • Melin C, Perraud A, Akil H, et al. Cancer stem cell sorting from colorectal cancer cell lines by sedimentation field flow fractionation. Anal Chem. 2012;84:1549–1556. doi:10.1021/ac202797z. PMID:22236375
  • Martins-Neves SR, Lopes AO, do Carmo A, et al. Therapeutic implications of an enriched cancer stem-like cell population in a human osteosarcoma cell line. BMC Cancer. 2012;12:139. doi:10.1186/1471-2407-12-139. PMID:22475227
  • Chen Y, Li D, Wang D, et al. Quiescence and attenuated DNA damage response promote survival of esophageal cancer stem cells. J Cell Biochem. 2012;113:3643–3652. doi:10.1002/jcb.24228. PMID:22711554
  • Roesch A, Fukunaga-Kalabis M, Schmidt EC, et al. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell. 2010;141:583–594. doi:10.1016/j.cell.2010.04.020. PMID:20478252
  • Palapattu GS, Wu C, Silvers CR, et al. Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer. The Prostate. 2009;69:787–798. doi:10.1002/pros.20928. PMID:19189306
  • Dembinski JL, Krauss S. Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma. Clin Exp Metastas. 2009;26:611–623. doi:10.1007/s10585-009-9260-0.
  • Seigel GM, Hackam AS, Ganguly A, et al. Human embryonic and neuronal stem cell markers in retinoblastoma. Mol Vis. 2007;13:823–832. PMID:17615543
  • Ozolek JA, Jane EP, Krowsoski L, et al. Human embryonic stem cells (HSF-6) show greater proliferation and apoptoses when grown on glioblastoma cells than mouse embryonic fibroblasts at day 19 in culture: comparison of proliferation, survival, and neural differentiation on two different feeder cell types. Stem Cells Dev. 2007;16:403–412. doi:10.1089/scd.2006.0109. PMID:17610370
  • Ho MM, Ng AV, Lam S, et al. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res. 2007;67:4827–4833. doi:10.1158/0008-5472.CAN-06-3557. PMID:17510412
  • Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70. doi:10.1016/S0092-8674(00)81683-9. PMID:10647931
  • Richichi C, Brescia P, Alberizzi V, et al. Marker-independent method for isolating slow-dividing cancer stem cells in human glioblastoma. Neoplasia. 2013;15:840–847. doi:10.1593/neo.13662. PMID:23814495
  • Deleyrolle LP, Rohaus MR, Fortin JM, et al. Identification and isolation of slow-dividing cells in human glioblastoma using carboxy fluorescein succinimidyl ester (CFSE). J Vis Exp. 2012;(62):3918. doi:10.3791/3918. PMID:22565048
  • Xue Z, Yan H, Li J, et al. Identification of cancer stem cells in vincristine preconditioned SGC7901 gastric cancer cell line. J Cell Biochem. 2012;113:302–312. doi:10.1002/jcb.23356. PMID:21913215
  • Vincent Z, Urakami K, Maruyama K, et al. CD133-positive cancer stem cells from Colo205 human colon adenocarcinoma cell line show resistance to chemotherapy and display a specific metabolomic profile. Gen Cancer. 2014;5:250–260. doi:10.18632/genesandcancer.23. PMID:25221643
  • Zhao Y, Zhang W, Guo Z, et al. Inhibition of the transcription factor Sp1 suppresses colon cancer stem cell growth and induces apoptosis in vitro and in nude mouse xenografts. Oncol Rep. 2013;30:1782–1792. doi:10.3892/or.2013.2627. PMID:23877322
  • Campos B, Gal Z, Baader A, et al. Aberrant self-renewal and quiescence contribute to the aggressiveness of glioblastoma. J Pathol. 2014;234:23–33. doi:10.1002/path.4366. PMID:24756862
  • Sun Y, Kong W, Falk A, et al. CD133 (Prominin) negative human neural stem cells are clonogenic and tripotent. PloS One. 2009;4:e5498. doi:10.1371/journal.pone.0005498. PMID:19430532
  • Banelli B, Carra E, Barbieri F, et al. The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma. Cell Cycle. 2015;14:3418–3429. doi:10.1080/15384101.2015.1090063. PMID:26566863
  • Hussein D, Punjaruk W, Storer LC, et al. Pediatric brain tumor cancer stem cells: cell cycle dynamics, DNA repair, and etoposide extrusion. Neuro-Oncol. 2011;13:70–83. doi:10.1093/neuonc/noq144. PMID:20978004
  • Li L, Li B, Shao J, et al. Chemotherapy sorting can be used to identify cancer stem cell populations. Mol Biol Rep. 2012;39:9955–9963. doi:10.1007/s11033-012-1864-9. PMID:22744428
  • Kobayashi S, Yamada-Okabe H, Suzuki M, et al. LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution. Stem Cells. 2012;30:2631–2644. doi:10.1002/stem.1257. PMID:23081779
  • Li HZ, Yi TB, Wu ZY. Suspension culture combined with chemotherapeutic agents for sorting of breast cancer stem cells. BMC Cancer. 2008;8:135. doi:10.1186/1471-2407-8-135. PMID:18477410
  • Cole JM, Joseph S, Sudhahar CG, et al. Enrichment for chemoresistant ovarian cancer stem cells from human cell lines. J Vis Exp. 2014;(91):51891. doi:10.3791/51891. PMID:25285606
  • Hubert CG, Rivera M, Spangler LC, et al. A three-dimensional organoid culture system derived from human glioblastomas recapitulates the hypoxic gradients and cancer stem cell heterogeneity of tumors found in vivo. Cancer Res. 2016;76:2465–2477. doi:10.1158/0008-5472.CAN-15-2402. PMID:26896279
  • Li P, Zhou C, Xu L, et al. Hypoxia enhances stemness of cancer stem cells in glioblastoma: an in vitro study. Int J Med Sci. 2013;10:399–407. doi:10.7150/ijms.5407. PMID:23471193
  • Zhang B, Tsai PC, Gonzalez-Celeiro M, et al. Hair follicles' transit-amplifying cells govern concurrent dermal adipocyte production through Sonic Hedgehog. Gen Dev. 2016;30:2325–2338. doi:10.1101/gad.285429.116.
  • Ostyn P, El Machhour R, Begard S, et al. Transient TNF regulates the self-renewing capacity of stem-like label-retaining cells in sphere and skin equivalent models of melanoma. Cell Commun Signal: CCS. 2014;12:52. doi:10.1186/s12964-014-0052-z. PMID:25223735
  • De Donatis A, Ranaldi F, Cirri P. Reciprocal control of cell proliferation and migration. Cell Commun and Signal: CCS. 2010;8:20. doi:10.1186/1478-811X-8-20. PMID:20822514
  • Kusumbe AP, Bapat SA. Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy. Cancer Res. 2009;69:9245–9253. doi:10.1158/0008-5472.CAN-09-2802. PMID:19951996
  • Billiau A, Edy VG, Heremans H, et al. Human interferon: mass production in a newly established cell line, MG-63. Antimicrob Agents Chemoth. 1977;12:11–15. doi:10.1128/AAC.12.1.11. PMID:883813
  • Kofman AV, Kim J, Park SY, et al. microRNA-34a promotes DNA damage and mitotic catastrophe. Cell Cycle. 2013;12:3500–3511. doi:10.4161/cc.26459. PMID:24091633
  • Fuchs E, Horsley V. Ferreting out stem cells from their niches. Nat Cell Biol. 2011;13:513–518. doi:10.1038/ncb0511-513. PMID:21540847

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.